218 related articles for article (PubMed ID: 30223881)
1. Superiority and non-inferiority: two sides of the same coin?
Dunn DT; Copas AJ; Brocklehurst P
Trials; 2018 Sep; 19(1):499. PubMed ID: 30223881
[TBL] [Abstract][Full Text] [Related]
2. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
Ganju J; Rom D
Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
[TBL] [Abstract][Full Text] [Related]
3. Regional consistency and sample size considerations in a multiregional equivalence trial.
Wu SC; Xu JF; Zhang XJ; Li ZW; He J
Pharm Stat; 2020 Nov; 19(6):897-908. PubMed ID: 32716135
[TBL] [Abstract][Full Text] [Related]
4. Non-inferiority trials in cardiology: what clinicians need to know.
Leung JT; Barnes SL; Lo ST; Leung DY
Heart; 2020 Jan; 106(2):99-104. PubMed ID: 31672779
[TBL] [Abstract][Full Text] [Related]
5. Optimal Use of the Non-Inferiority Trial Design.
Angeli F; Verdecchia P; Vaudo G; Masnaghetti S; Reboldi G
Pharmaceut Med; 2020 Jun; 34(3):159-165. PubMed ID: 32277352
[TBL] [Abstract][Full Text] [Related]
6. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
Hirotsu C
Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the design and analysis of non-inferiority trials: a case study.
Durkalski V; Silbergleit R; Lowenstein D
Clin Trials; 2011 Oct; 8(5):601-8. PubMed ID: 21921062
[TBL] [Abstract][Full Text] [Related]
8. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
Shao Y; Mukhi V; Goldberg JD
Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
[TBL] [Abstract][Full Text] [Related]
9. [Methodology for superiority versus equivalence and non-inferior clinical studies. A practical review].
Rosas-Peralta M; Santos-Martínez LE; Magaña-Serrano JA; Valencia-Sánchez JS; Garrido-Garduño M; Pérez-Rodríguez G
Rev Med Inst Mex Seguro Soc; 2016; 54(3):344-53. PubMed ID: 27100981
[TBL] [Abstract][Full Text] [Related]
10. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
Weir IR; Trinquart L
Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
[TBL] [Abstract][Full Text] [Related]
11. Methodological aspects of superiority, equivalence, and non-inferiority trials.
Stefanos R; Graziella D'; Giovanni T
Intern Emerg Med; 2020 Sep; 15(6):1085-1091. PubMed ID: 32705494
[TBL] [Abstract][Full Text] [Related]
12. Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings.
May S; Brown SP; Schmicker RH; Emerson SS; Nkwopara E; Ginsburg AS
Clin Trials; 2020 Apr; 17(2):129-137. PubMed ID: 31814441
[TBL] [Abstract][Full Text] [Related]
13. Methodology of superiority vs. equivalence trials and non-inferiority trials.
Christensen E
J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
[TBL] [Abstract][Full Text] [Related]
14. Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials.
Wiens BL
J Biopharm Stat; 2018; 28(1):52-62. PubMed ID: 29065276
[TBL] [Abstract][Full Text] [Related]
15. Non-inferiority trials in breast and non-small cell lung cancer: choice of non-inferiority margins and other statistical aspects.
Saad ED; Buyse M
Acta Oncol; 2012 Sep; 51(7):890-6. PubMed ID: 22974094
[TBL] [Abstract][Full Text] [Related]
16. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
[TBL] [Abstract][Full Text] [Related]
17. When inferiority meets non-inferiority: implications for interim analyses.
Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
[TBL] [Abstract][Full Text] [Related]
18. [Non-inferiority and equivalence trials: Key methodological issues].
Herr M; Descatha A; Aegerter P
Rev Med Interne; 2018 May; 39(5):352-359. PubMed ID: 28693836
[TBL] [Abstract][Full Text] [Related]
19. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.
Rehal S; Morris TP; Fielding K; Carpenter JR; Phillips PP
BMJ Open; 2016 Oct; 6(10):e012594. PubMed ID: 27855102
[TBL] [Abstract][Full Text] [Related]
20. Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.
Althunian TA; de Boer A; Klungel OH; Insani WN; Groenwold RH
Trials; 2017 Mar; 18(1):107. PubMed ID: 28270184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
